Agios Pharmaceuticals
AGIO
AGIO
178 hedge funds and large institutions have $2.69B invested in Agios Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $3.07B → $2.69B (-$388M)
33% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $15.1M
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
178
Holding in Top 10
1
Calls
$10.2M
Puts
$15.1M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$13.4M | |
| 3 | +$12.8M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$12.1M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$9.68M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$12M | |
| 3 | -$9.28M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.89M |
| 5 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$7.38M |